Indication
Prevention of relapse to opioid dependence
Prevention of relapse to opioid dependence refers to a clinical maintenance phase in individuals with opioid use disorder who have successfully undergone detoxification and achieved medically supervised opioid abstinence. Read more about Prevention of relapse to opioid dependence
56 drugs 47 manufacturers
Drugs that treat it
Common Prevention of relapse to opioid dependence therapies.
NALTREXONE HCL
NALTREXONE HCL
BUNAVAIL (buprenorphine HCl/naloxone HCl)
NALTREXONE HCL
BUPRENORPHINE HCL
BUPRENORPHINE HCL
BUPRENORPHINE HCL
BUPRENORPHINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of relapse to opioid dependence refers to a clinical maintenance phase in individuals with opioid use disorder who have successfully undergone detoxification and achieved medically supervised opioid abstinence.
This post-withdrawal state affects the central nervous system, where persistent neuroadaptations in brain reward and stress pathways leave individuals vulnerable to intense cravings, conditioned environmental cues, and recurrent nonmedical opioid consumption.
Clinically, it targets the critical vulnerability period following detoxification when loss of pharmacologic tolerance dramatically elevates the risk of fatal overdose upon any resumption of opioid use.
Interventions for this indication focus on stabilizing neurobiological function and preventing the re-establishment of physical dependence and compulsive use patterns.
- nih.gov
Prevention of relapse to opioid dependence refers to a clinical maintenance phase in individuals with opioid use disorder who have successfully undergone detoxification and achieved medically supervised opioid abstinence
- pcssnow.org
Prevention of relapse to opioid dependence refers to a clinical maintenance phase in individuals with opioid use disorder who have successfully undergone detoxification and achieved medically supervised opioid abstinence Interventions for this indication focus on stabilizing neurobiological function and preventing the re-establishment of physical dependence and compulsive use patterns
- milehightr.com
This post-withdrawal state affects the central nervous system, where persistent neuroadaptations in brain reward and stress pathways leave individuals vulnerable to intense cravings, conditioned environmental cues, and recurrent nonmedical opioid consumption
- issup.net
This post-withdrawal state affects the central nervous system, where persistent neuroadaptations in brain reward and stress pathways leave individuals vulnerable to intense cravings, conditioned environmental cues, and recurrent nonmedical opioid consumption
- uams.edu
Clinically, it targets the critical vulnerability period following detoxification when loss of pharmacologic tolerance dramatically elevates the risk of fatal overdose upon any resumption of opioid use
- nih.gov
Interventions for this indication focus on stabilizing neurobiological function and preventing the re-establishment of physical dependence and compulsive use patterns
Personalize your experience
Follow Prevention of relapse to opioid dependence and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.